Prostate cancer

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Scopus citations

Abstract

Prostate cancer is one of the most common malignancies in American men, second only to non-melanoma skin cancer. In 2009, an estimated 192,280 new cases of prostate cancer were diagnosed in the United States, and about 27,360 men died of this disease [1]. The median age at diagnosis is 68 years, and the risk of developing the disease increases in men with advancing age, in those with an affected first-degree relative, and in African American men. The behavior of prostate cancer can vary from a microscopic, well-differentiated cancer with a slow clinical course to an aggressive, poorly differentiated cancer with the potential to invade and spread. Men with prostate cancer can be broadly staged as having localized disease (confined to the prostate), regional disease (i.e., spread to periprostatic fat, seminal vesicles, or pelvic lymph nodes), or distant disease (which metastasizes most commonly to distant lymph nodes and bone).

Original languageEnglish (US)
Title of host publication60 Years of Survival Outcomes at The University of Texas MD Anderson Cancer Center
PublisherSpringer New York
Pages35-43
Number of pages9
ISBN (Electronic)9781461451976
ISBN (Print)1461451965, 9781461451969
DOIs
StatePublished - Aug 1 2013

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Prostate cancer'. Together they form a unique fingerprint.

Cite this